RKLBRocket Lab

Investment Thesis

Rocket Lab is the only U.S.-listed pure-play launch + space systems company with meaningful revenue and growing flight cadence. Q1 FY2026 revenue was $200M (+63.5% YoY); backlog exceeded $2.2B (doubled YoY); gross margin is +33.5%. The company is vertically integrated (engines, avionics, spacecraft, solar arrays, star trackers, optical inter-satellite links) — a rarity in aerospace and a structural moat. Neutron (medium-lift rocket) maiden flight is planned for H2 2026. Nasdaq-100 inclusion (June 12, 2026) creates mechanical ETF inflows. SpaceX IPO (June 12, 2026) is a shadow-stock comps catalyst for RKLB driving re-rating potential.

The thesis is multi-layer: (1) Rocket Lab is the enabler for SDA Proliferated LEO constellation (won $816M SDA Tranche 3 prime contract); (2) Neutron unlocks larger payload capacities and commercial market expansion (medium-lift is under-served by launch providers); (3) Space Systems division (40%+ of revenue) embedded in ~30% of all orbiting satellites creates distributed revenue stream independent of launch cadence and provides margin stability.

Entry point: Nasdaq-100 Inclusion + SpaceX IPO comps re-rating drove +42.6% single session run; macro risk-off pullback (-26.1% month, -25.27% macro-driven) has brought stock back to entry range ($100–115). Thesis intact; no macro invalidation. Hold position and let catalysts resolve in H2 2026.

Physical AI / Value-Chain Relevance

Rocket Lab operates at Layer 11 — Autonomy Software, Fleet Platforms & End Markets. It is the launch + spacecraft prime contractor for the space layer of Physical AI defense systems enabling autonomous coordination and real-time targeting.

The SDA Proliferated LEO constellation (Golden Dome missile defense system) depends entirely on launch cadence and spacecraft availability. Rocket Lab's small-launch (Electron) and medium-lift (Neutron) vehicles enable frequent, responsive launch cadences required by SDA deployment schedules. Space Systems components (reaction wheels, solar arrays, star trackers, optical inter-satellite links) are embedded in every satellite. The company is not just the launch provider; it is the spacecraft prime and component supplier — triple-layer revenue model for the SDA buildout and broader defense space infrastructure.

Catalysts

• Neutron maiden flight (H2 2026): First medium-lift flight validates Rocket Lab's engineering; unlocks larger payload capacity for commercial and government constellations, expanding addressable market.
• SDA Tranche 3 contract milestones: $816M SDA Tranche 3 contract SRR passed May 2026; next gate is PDR and manufacturing ramp, confirming execution.
• Space Systems revenue inflection: Components in ~30% of all orbiting satellites; volume grows with commercial constellation deployments (Starlink, Amazon Kuiper, international).
• Mynaric optical inter-satellite links (ISL) deployment: Acquisition adds laser comms capability critical for SDA constellation real-time data relay and reduces latency.
• CEO equity alignment: Beck zeroed own salary for equity; signals conviction in execution and alignment with shareholders.

Positioning / What the Market May Be Missing

The market is distracted by technicals (-26% month on macro risk-off, down from $113.65 entry to $85.39) and missing the structural inflection. Nasdaq-100 inclusion brings passive index flows; SpaceX IPO provides comps lifting for all space pure-plays. Quantum of ETF inflows is material — RKLB was not in SPY, IVV, or VOO; Nasdaq-100 adds it to QQQ and derivatives, likely worth +5–10% mechanical lift over 2–4 weeks as money flows into index trackers.

Space Systems revenue (40%+ of total) is unrecognized as a moat: Rocket Lab is not dependent on launch cadence; it earns revenue on spacecraft and components independent of Electron/Neutron flight rate. This stabilizes revenue during development phases (Neutron) and creates distributed market diversification across multiple customer classes.

$2.2B backlog doubled YoY — this is not speculative backlog; it includes binding government contracts (SDA Tranche 3, NRO programs) and commercial constellation deployment agreements with hyperscalers seeking internet coverage.

Risks and What Invalidates the Thesis

• Neutron delay >12 months: Program delays push revenue inflection into 2027; valuation multiple compresses materially and backlog credibility questioned.
• SDA budget cuts or schedule slips: Tranche 2/3 delays or funding reductions cascade into RKLB revenue visibility and backlog conversion uncertainty.
• SpaceX dominance in launch market: Starship IPO success and FTS (flight-termination system) qualification could compress Electron/Neutron market share and addressable market.
• Cash burn above $400M/yr without revenue offset: If burn continues at Q1 pace and Neutron revenue doesn't materialize in H2 2026, capital raise required at potentially dilutive terms.
• Valuation compression from macro volatility: Any sustained recession could re-rate space/aerospace sector lower, overriding Physical AI fundamentals and growth story.

What to Watch Next

1. Neutron maiden flight (H2 2026): On-time delivery confirms engineering competency; any slips extend risk and delay revenue recognition by quarters.
2. Q2/Q3 FY2026 earnings calls: Backlog reaffirmation, Neutron development status, cash burn guidance, and Space Systems revenue confirmation.
3. SDA Tranche 2 award announcement: Next-phase funding extends RKLB revenue runway; timing and scope critical to valuation.
4. Space Systems revenue mix: Track component/services revenue as % of total; confirm >35% composition and growth trajectory.
5. SpaceX IPO comps impact: Monitor analyst note comparisons between RKLB and SpaceX; re-rating scenarios and multiple expansion potential.